Drug Related Problems in Patients Hospitalized to a Community Hospital within Three Border Southern Provinces and Management of the Problems by Pharmacist
Article Sidebar
Main Article Content
Abstract
Objective: To study frequency, type, severity, causes of drug related problems (DRPs), including planned interventions, intervention acceptance, intervention outcomes for patients hospitalized to a community hospital located in three southern border provinces. Methods: This research was a descriptive study. Subjects were 282 inpatients admitted to inpatient ward of a community hospital located in three southern border provinces. Data were collected by reviewing treatment history, medication history, and drugs prescribed in each day of stay. Interview with the patients and their care-givers was also conducted to collect more information. Information was used to identify DRPs and management of DRPs according to the Pharmaceutical Care Network Europe (PCNE) V.8.02. Severity of DRPs was classified according to the NCC MERP index. The study measured satisfaction of patients and medical personnel using the questionnaire. Results: Mean age of subjects was 39.2±27.7 years with average lengths of stay 4.4±4.2 days. DRPs were found in 19.5% of patients with the total of 72 DRPs or an average of 1.3±0.6 DRPs per patient. Seventy-eight percent of the DRPs was related to treatment effectiveness. The severity of 33.33% of DRPs was at level D (the events reached the patients, and intensive special care is needed). Forty percent of causes of DRPs were related to patients. The intervention for 36.8% of DRPs was at the prescriber level. Acceptance among physicians, patients and care-givers was achieved in 97.2% of the intervention of pharmacists. 84.7% of interventions were successful in resolving the problems. 90.9% of health personnel were satisfied with DRP management. Conclusion: The majority of DRPs identified in patient wards were rather severe. Interventions to resolve DRPs by pharmacist were well accepted and were able to resolve a large number of DRPs.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Vo TH. Evaluation of the potential impact of pharma cist interventions development and validation of the CLEO multidimensional tool [master thesis]. Grenoble : Grenoble-Alpes University; 2015.
3. Nielsen TR, Andersen SE, Rasmussen M, Honoré PH. Clinical pharmacist service in acute ward. Int J Clin Pharm 2013; 1137–51.
4.Nibal A, Anfal E, Fatih MV, Mesut S. Drug related problems identified by clinical pharmacist at the internal medicine ward in Turkey. Int J Clin Pharm 2018; 40: 360–7.
5. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192–9.
6. Sawasdeephanich J. Primary pharmaceutical care services among patients with chronic kidney disease Kantharawichai hospital, Mahasarakham province. Research and Development Health System Journal 2008; 1: 57–63.
7. Nuntasaen T, Soontornpas R, Mootsikapun P, Soon tornpas C. Root cause analysis of related problems in drug use of patients with HIV Infection: A case study at Srinagarind hospital. Srinagarind Medical Journal 2015; 30: 221–8.
8. Chanatepaporn P, Soontornpas C. Pharmacist roles in patients with acute coronary syndrome in medical wards at Srinagarind hospital. Isan Journal of Pharma ceutical sciences 2006; 2: 54–65.
9. Boonpratueng W. Development of pharmaceutical care service at medical ward of King Chulalongkorn Memorial hospital [master thesis]. Bangkok: Chula longkorn University; 2001.
10. Kulprom W. Inpatient pharmaceutical care at Chattu rus community hospital [master thesis]. Bangkok: Chulalongkorn University; 1999.
11. Chanatepaporn P. Assessments of pharmaceutical care in female-medical ward in university hospital. Srinagarind Medical Journal 2006; 21: 282–8.
12. Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 1987; 79: 718–22.
13. Iafrate RP. Documenting medication errors averted by pharmacists. Am J Hosp Pharm 1986;43: 1672-3.
14. Mueller BA, Abel SR. Impact of college of pharmacy-based educational services within the hospital. DICP 1990; 24: 422–5.
15. Western Australian Clinical Pharmacists Group. Recording clinical pharmacist interventions: is there a better way? Austr J Hosp Pharm.1991; 21: 158–62.
16. Eadon H. Assessing the quality of ward pharmacists’ interventions. Int J Pharm Pract 1992; 1: 145–7.
17. Pharmaceutical Care Network Europe Foundation. PCNE classification for drug related problems V 8.02 [online]. 2017.[cited Jul 31, 2017]. Available from: www.pcne.org/upload/files/230_PCNE_classification_V8-02.pdf.
18.Cochran WG. Sampling techniques.2nd ed., New York: John Wiley and Sons; 1963.
19. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error reporting program. Am J Hosp Pharm 1991; 48: 2611 –6.
